These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6967909)

  • 1. The expression of deoxyguanosine toxicity in T lymphocytes at different stages of maturation.
    Cohen A; Lee JW; Dosch HM; Gelfand EW
    J Immunol; 1980 Oct; 125(4):1578-82. PubMed ID: 6967909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activities of enzymes of purine metabolism in murine thymus dependent lymphocytes.
    Sidi Y; Livne P; Brosh S; Pecht M; Shilder D; Pinkhas J; Trainin N; Sperling O
    Biomed Pharmacother; 1984; 38(9-10):455-8. PubMed ID: 6099152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency.
    Fairbanks LD; Taddeo A; Duley JA; Simmonds HA
    J Immunol; 1990 Jan; 144(2):485-91. PubMed ID: 2104895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes.
    Ma DD; Sylwestrowicz TA; Granger S; Massaia M; Franks R; Janossy G; Hoffbrand AV
    J Immunol; 1982 Oct; 129(4):1430-5. PubMed ID: 6286766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency.
    North ME; Newton CA; Webster AD
    Clin Exp Immunol; 1980 Dec; 42(3):523-9. PubMed ID: 6783354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of deoxyguanosine resistance by TPA-induced T lymphoid lines.
    Sacchi N; Fiorini G; Plevani P; Badaracco G; Breviario D; Ginelli E
    J Immunol; 1983 Apr; 130(4):1622-6. PubMed ID: 6601131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro.
    Spaapen LJ; Rijkers GT; Staal GE; Rijksen G; Wadman SK; Stoop JW; Zegers BJ
    J Immunol; 1984 May; 132(5):2311-7. PubMed ID: 6425399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of deoxyguanosine on human lymphocyte function. II. Analysis of the interference with B lymphocyte differentiation in vitro.
    Spaapen LJ; Rijkers GT; Staal GE; Rijksen G; Duran M; Stoop JW; Zegers BJ
    J Immunol; 1984 May; 132(5):2318-23. PubMed ID: 6425400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine nucleoside phosphorylase deficiency: a molecular model for selective loss of T cell function.
    Ochs UH; Chen SH; Ochs HD; Osborne WR; Scott CR
    J Immunol; 1979 Jun; 122(6):2424-9. PubMed ID: 109531
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell culture observations of human postnatal thymic epithelium: an in vitro model for growth and humoral influence on intrathymic T lymphocyte maturation.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1996; 10(5):515-26. PubMed ID: 8899432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
    Dong MK; Scott ME; Schrier DJ; Suto MJ; Sircar JC; Black A; Chang T; Gilbertsen RB
    J Pharmacol Exp Ther; 1992 Jan; 260(1):319-26. PubMed ID: 1530976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective toxicity of deoxyguanosine and arabinosyl guanine for T-leukemic cells.
    Cohen A; Lee JW; Gelfand EW
    Blood; 1983 Apr; 61(4):660-6. PubMed ID: 6600944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and immunological differentiation of human thymocytes induced by thymic hormones.
    Ho AD; Ma DD; Price G; Hunstein W; Hoffbrand AV
    Immunology; 1983 Nov; 50(3):471-6. PubMed ID: 6605305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different pathways for deoxyguanosine toxicity in T-lymphocytes of various developmental stages.
    Scharenberg JG; Rijkers GT; Spaapen LJ; Toebes EA; Rijksen G; Duran M; Staal GE; Zegers BJ
    Int J Immunopharmacol; 1988; 10(6):675-86. PubMed ID: 2974022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor--BCX-1777.
    Bantia S; Ananth SL; Parker CD; Horn LL; Upshaw R
    Int Immunopharmacol; 2003 Jun; 3(6):879-87. PubMed ID: 12781704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human CD45RC specificity. A novel marker for T cells at different maturation and activation stages.
    Zapata JM; Pulido R; Acevedo A; Sánchez-Madrid F; de Landázuri MO
    J Immunol; 1994 Apr; 152(8):3852-61. PubMed ID: 8144955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic death induced in MOLT-4 T-lymphoblasts by purine nucleoside phosphorylase inhibition.
    Gilbertsen RB; Posmantur R; Nath R; Wang KK
    Inflamm Res; 1997 Aug; 46 Suppl 2():S151-2. PubMed ID: 9297556
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of 2'deoxyguanosine on human lymphocyte responses. I. 2'deoxyguanosine enhances T lymphocyte responses.
    Hanglow AC; Lydyard PM
    Clin Exp Immunol; 1985 Mar; 59(3):653-8. PubMed ID: 3872754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential metabolism of guanine nucleosides by human lymphoid cell lines.
    Mitchell BS; Sidi Y
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):427-31. PubMed ID: 3875100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of leukemic human null lymphocytes to deoxynucleosides.
    Fox RM; Tripp EH; Piddington SK; Tattersall MH
    Cancer Res; 1980 Sep; 40(9):3383-6. PubMed ID: 6253063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.